sucrose and Hemorrhage

sucrose has been researched along with Hemorrhage in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19903 (13.64)18.7374
1990's1 (4.55)18.2507
2000's12 (54.55)29.6817
2010's5 (22.73)24.3611
2020's1 (4.55)2.80

Authors

AuthorsStudies
Ay, Y; Cubukcu, D; Gozmen, S; Karapinar, TH; Oymak, Y; Toret, E; Vergin, RC1
Beckmann, H; Hou, Q; Hu, Y; Sun, J; Wu, J; Wu, R; Xiao, J; Yang, R; Zhao, Y1
Bonanad, S; Bosch, P; Cid, AR; Haya, S; Marqués, MR; Megías-Vericat, JE; Monte-Boquet, E; Pérez-Alenda, S; Poveda, JL; Querol, F1
Gercheva, L; Ghinea, M; Goranov, S; Hong, W; Kempton, CL; Lissitchkov, T; Manco-Johnson, MJ; Reding, MT; Rescia, V; Rusen, L; Uscatescu, V1
Delesen, H; Enriquez, MM; Lalezari, S; Martinowitz, U; Scharrer, I; Schwartz, L; Windyga, J1
Andreeva, TA; Khametova, RN; Plyushch, OP; Spira, J1
Konigs, C; von Hentig, N1
Di Minno, G; Hellmann, A; Ingerslev, J; Maas Enriquez, M; Martinowitz, U; Pabinger, I; Powell, J; Schwartz, L; Windyga, J1
Shi, J; Sun, J; Wang, L; Wu, J; Yang, R; Zhao, Y1
Powell, JS1
Faradji, A; Gorina, E; Ingerslev, J; Iorio, A; Lambert, T; Maas-Enriquez, M; Musso, R; Santagostino, E; van der Meer, J1
Frampton, JE; Wagstaff, AJ1
Ishihara, H; Iwakawa, T; Sakai, I; Suzuki, A; Takamura, K1
Abshire, TC; Brackmann, HH; Gazengel, C; Gorina, E; Hoots, K; Kellermann, E; Powell, JS; Scharrer, I; Vosburgh, E1
Fukutake, K; Shima, M; Shirahata, A; Takamatsu, J; Yoshioka, A2
Biagioli, EC; Biagiotti, R; Gambi, B; Martelli, E; Pezzati, M; Rubaltelli, FF1
Anderson, WG; Hazon, N; Takei, Y1
Brooks, CC; Miyahara, AY; Nakamura, RM1
Dalderup, LM; Visser, W1
Dumkin, IM1
Amer, S; Hayasidani, H; Hikosaka, K; Hirota, Y; Kang, CB; Koge, K; Koyama, Y; Motobu, M; Nakamura, K; Sameshima, T; Yamada, M1

Reviews

2 review(s) available for sucrose and Hemorrhage

ArticleYear
A review of current literature on second-generation, sucrose-formulated, full-length recombinant factor VIII.
    Drugs of today (Barcelona, Spain : 1998), 2009, Volume: 45, Issue:7

    Topics: Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Excipients; Factor VIII; Hemophilia A; Hemorrhage; Humans; Sucrose

2009
Sucrose-formulated octocog alfa: a review of its use in patients with haemophilia A.
    Drugs, 2008, Volume: 68, Issue:6

    Topics: Blood Loss, Surgical; Chemistry, Pharmaceutical; Coagulants; Excipients; Factor VIII; Hemophilia A; Hemorrhage; Humans; Sucrose; Treatment Outcome

2008

Trials

9 trial(s) available for sucrose and Hemorrhage

ArticleYear
Efficacy of standard prophylaxis versus on-demand treatment with bayer's sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with severe hemophilia A.
    Pediatric hematology and oncology, 2017, Volume: 34, Issue:3

    Topics: Adolescent; Asian People; Child; Child, Preschool; China; Factor VIII; Female; Follow-Up Studies; Hemophilia A; Hemorrhage; Humans; Male; Sucrose; Time Factors

2017
Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART).
    Journal of thrombosis and haemostasis : JTH, 2013, Volume: 11, Issue:6

    Topics: Adolescent; Adult; Drug Administration Schedule; Factor VIII; Hemophilia A; Hemorrhage; Humans; International Cooperation; Magnetic Resonance Imaging; Male; Middle Aged; Quality of Life; Sucrose; Treatment Outcome; Young Adult

2013
Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2014, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Blood Coagulation Tests; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Factor VIII; Hemophilia A; Hemorrhage; Humans; Male; Middle Aged; Premedication; Severity of Illness Index; Sucrose; Treatment Outcome; von Willebrand Factor; Young Adult

2014
Evaluation of liposomal dose in recombinant factor VIII reconstituted with pegylated liposomes for the treatment of patients with severe haemophilia A.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:3

    Topics: Adult; Cross-Over Studies; Factor VIII; Hemophilia A; Hemorrhage; Humans; Liposomes; Male; Middle Aged; Models, Genetic; Polyethylene Glycols; Safety; Sucrose; Time Factors; Treatment Outcome

2008
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:5

    Topics: Adolescent; Adult; Chemistry, Pharmaceutical; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Factor VIII; Hemophilia A; Hemorrhage; Humans; Liposomes; Male; Middle Aged; Polyethylene Glycols; Solvents; Sucrose; Treatment Outcome; Young Adult

2012
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:1

    Topics: Adolescent; Adult; Blood Coagulation Factor Inhibitors; Blood Loss, Surgical; Chemistry, Pharmaceutical; Child; Child, Preschool; Coagulants; Europe; Excipients; Factor VIII; Hemophilia A; Hemorrhage; Humans; Infant; Infusions, Parenteral; Male; Product Surveillance, Postmarketing; Prospective Studies; Recombinant Proteins; Severity of Illness Index; Sucrose; Time Factors; Treatment Outcome

2008
Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:6

    Topics: Adolescent; Adult; Antibodies; Child; Cross-Over Studies; Drug Compounding; Drug Evaluation; Factor VIII; Hemophilia A; Hemorrhage; Home Infusion Therapy; Humans; Male; Middle Aged; Partial Thromboplastin Time; Patient Satisfaction; Recombinant Proteins; Sucrose; Time Factors; Treatment Outcome

2000
Pharmacokinetics, prophylactic effects, and safety of a new recombinant FVIII formulated with sucrose (BAY 14-2222) in Japanese patients with hemophilia A.
    International journal of hematology, 2000, Volume: 72, Issue:1

    Topics: Adolescent; Adult; Child; Consumer Product Safety; Drug Evaluation; Factor VIII; Half-Life; Hemophilia A; Hemorrhage; Humans; Japan; Male; Middle Aged; Recombinant Proteins; Sucrose

2000
Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2001, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Child; Cohort Studies; Consumer Product Safety; Drug Combinations; Factor VIII; Hemophilia A; Hemorrhage; Hemostasis; Humans; Isoantibodies; Japan; Longitudinal Studies; Middle Aged; Recombinant Proteins; Sucrose; Therapeutic Equivalency

2001

Other Studies

11 other study(ies) available for sucrose and Hemorrhage

ArticleYear
Which tests can most effectively indicate the clinical phenotype of paediatric haemophilia patients with prophylaxis?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, Jun-01, Volume: 32, Issue:4

    Topics: Adolescent; Blood Coagulation Tests; Child; Factor VIII; Hemophilia A; Hemorrhage; Humans; Sucrose; Thrombelastography; Thrombin

2021
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate
    Haemophilia : the official journal of the World Federation of Hemophilia, 2019, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Child; Cross-Sectional Studies; Drug Compounding; Factor VIII; Female; Hemophilia A; Hemorrhage; Humans; Middle Aged; Sucrose; Treatment Outcome; Young Adult

2019
Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2007, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Child; China; Drug Evaluation; Factor VIII; Hemophilia A; Hemorrhage; Humans; Middle Aged; Risk Factors; Sucrose

2007
Liposomal approach towards the development of a longer-acting factor VIII.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2007, Volume: 13 Suppl 2

    Topics: Animals; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Factor VIII; Hemorrhage; Hemostasis; Humans; Liposomes; Mice; Models, Animal; Random Allocation; Sucrose; Treatment Outcome

2007
Measurements of extracellular fluid volume in highly perfused organs and lung water in hypo- and hypervolaemic dogs.
    European journal of anaesthesiology, 1998, Volume: 15, Issue:4

    Topics: Animals; Blood Glucose; Blood Pressure; Body Fluids; Cardiac Output; Central Venous Pressure; Dogs; Edema; Extracellular Space; Extravascular Lung Water; Female; Glucose; Heart Rate; Hemorrhage; Indicator Dilution Techniques; Isotonic Solutions; Linear Models; Male; Pulmonary Wedge Pressure; Ringer's Lactate; Sucrose; Tissue Distribution

1998
Umbilical cord care: the effect of eight different cord-care regimens on cord separation time and other outcomes.
    Biology of the neonate, 2002, Volume: 81, Issue:1

    Topics: Bacitracin; Benzoyl Peroxide; Coloring Agents; Delivery, Obstetric; Hemorrhage; Humans; Infant Mortality; Infant, Newborn; Neomycin; Patient Compliance; Patient Satisfaction; Prospective Studies; Rosaniline Dyes; Salicylic Acid; Sepsis; Silver; Sucrose

2002
Osmotic and volaemic effects on drinking rate in elasmobranch fish.
    The Journal of experimental biology, 2002, Volume: 205, Issue:Pt 8

    Topics: Animals; Blood Chemical Analysis; Blood Physiological Phenomena; Drinking Behavior; Elasmobranchii; Female; Hemorrhage; Hydrogen-Ion Concentration; Male; Osmolar Concentration; Seawater; Sodium Chloride; Species Specificity; Sucrose

2002
Effect of menadione and other factors on sugar-induced heart lesions and hemorrhagic syndrome in the pig.
    Journal of animal science, 1973, Volume: 37, Issue:6

    Topics: Animals; Chlortetracycline; Dietary Carbohydrates; Female; Glucose; Heart Diseases; Hemorrhage; Male; Prothrombin Time; Rats; Salicylates; Sucrose; Swine; Swine Diseases; Syndrome; Vitamin K

1973
Influence of extra sucrose, fats, protein and of cyclamate in the daily food on the life-span of rats.
    Experientia, 1971, May-15, Volume: 27, Issue:5

    Topics: Adrenal Gland Diseases; Adrenal Glands; Animals; Body Weight; Bread; Butter; Cyclamates; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Glomerulonephritis; Hemorrhage; Infarction; Kidney; Liver; Longevity; Male; Meat; Necrosis; Organ Size; Pancreas; Rats; Sucrose; Testis; Vegetables

1971
[The use of blood preserved by the mass dilution method in surgical practice].
    Vestnik khirurgii imeni I. I. Grekova, 1966, Volume: 96, Issue:4

    Topics: Adolescent; Adult; Aged; Blood Preservation; Blood Transfusion; Bromides; Child; Child, Preschool; Citrates; Dehydration; Ethanol; Glucose; Hemorrhage; Humans; Hypoproteinemia; Middle Aged; Nitrofurazone; Plasma Substitutes; Postoperative Care; Protein Hydrolysates; Shock, Surgical; Shock, Traumatic; Sodium Chloride; Solutions; Sucrose; Sulfacetamide; Surgical Procedures, Operative

1966
Protective effects of sugar cane extract on endotoxic shock in mice.
    Phytotherapy research : PTR, 2006, Volume: 20, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythrocytes; Female; Galactosamine; Hemorrhage; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Saccharum; Salmonella; Shock, Septic; Tumor Necrosis Factor-alpha

2006